All research papers

Impact of a vacuum cushion on intrafraction motion during online adaptive MR-guided SBRT for pelvic and para-aortic lymph node oligometastases.

Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy With On-Table Adaptive Replanning and Elective Nodal Irradiation for Inoperable Pancreas Cancer.

Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.

The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.

Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy.

Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma.

Recent advanced in Surface Guided Radiation Therapy.

Improvement of prediction and classification performance for gamma passing rate by using plan complexity and dosiomics features.

Efficacy and safety of ²²⁵Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients.

Evaluation of radixact motion synchrony for 3D respiratory motion: Modeling accuracy and dosimetric fidelity.

Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging.

Patient-specific dose quality assurance of single-isocenter multiple brain metastasis stereotactic radiosurgery using PTW Octavius 4D.

Immune-Checkpoint Blockade Enhances ²²⁵Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer.

Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac.

In vivo dosimetry in external beam photon radiotherapy: Requirements and future directions for research, development, and clinical practice.

FAPI-74 PET/CT Using Either ¹⁸F-AlF or Cold-Kit ⁶⁸Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients.

Usefulness of [⁶⁸Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [¹⁸F]FDG PET/CT findings.

Radioprotective efficacy of plastic polymer against the toxicogenomic effects of radiopharmaceutical ¹⁸F-FDG on human lymphocytes.

Controlling evolution of protein corona: a prosperous approach to improve chitosan-based nanoparticle biodistribution and half-life.

Fibroblast Activation Protein-Targeted PET/CT with ⁶⁸Ga-FAPI for Imaging IgG4-Related Disease: Comparison to ¹⁸F-FDG PET/CT.

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial.

Magnetic resonance image (MRI) synthesis from brain computed tomography (CT) images based on deep learning methods for magnetic resonance (MR)-guided radiotherapy.

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers.

Commissioning of a 1.5T Elekta Unity MR-linac: A single institution experience.

4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience.

Technical Note: Comprehensive performance tests of the first clinical real-time motion tracking and compensation system using MLC and jaws.

Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [¹⁷⁷Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial).

Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms.

Medical physics challenges in clinical MR-guided radiotherapy.

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.

Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an ¹⁸F-Labeled FAP Inhibitor.

3D printing of radioactive phantoms for nuclear medicine imaging.

Error detection using a convolutional neural network with dose difference maps in patient-specific quality assurance for volumetric modulated arc therapy.

Accurate surgical navigation with real-time tumor tracking in cancer surgery.

The potential of an optical surface tracking system in non-coplanar single isocenter treatments of multiple brain metastases.

CBCT-based synthetic CT generation using deep-attention cycleGAN for pancreatic adaptive radiotherapy.

Comparison of [⁶⁸Ga]Ga-DOTA-FAPI-04 and [¹⁸F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer.

1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.

Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings.

Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and ¹⁸⁸Re Therapy.

Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.

Clinical Outcomes of Stereotactic MR-Guided Adaptive Radiation Therapy for High-Risk Lung Tumors.

Supply and Clinical Application of Actinium-225 and Bismuth-213.

Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure.

Current approaches to the management of brain metastases.

The Role of ⁶⁸Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience.

Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach.

Dosimetric impact of rotational errors on the quality of VMAT-SRS for multiple brain metastases: Comparison between single- and two-isocenter treatment planning techniques.

MRI-guided adaptive radiotherapy for liver tumours: visualising the future.

Automated GMP compliant production of [¹⁸F]AlF-NOTA-octreotide.

Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments.

Occupational radiation exposure of health professionals and cancer risk assessment for Lithuanian nuclear medicine workers.

Application of TG-218 action limits to SRS and SBRT pre-treatment patient specific QA.

¹⁸F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging.

Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity.

EANO guideline on the diagnosis and treatment of vestibular schwannoma.

Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging.

The management impact of ⁶⁸gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (⁶⁸Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancer.

Radiohybrid Ligands: A Novel Tracer Concept Exemplified by ¹⁸F- or ⁶⁸Ga-Labeled rhPSMA Inhibitors.